Phase 1 Start~month
Phase 1 Start: A Phase 1 Study With Expansion of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (M
Other upcoming events for MRKR
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.